Latest News

  • Alkermes to Host Conference Call to Discuss Second Quarter 2018 Financial Results Read More
  • FDA Approves ARISTADA INITIO™ for the Initiation of ARISTADA® for Schizophrenia Read More
  • Alkermes to Present at Goldman Sachs 39th Annual Global Healthcare Conference Read More

Investors

Working at Alkermes